Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88


Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Winter SS, Jiang Z, Khawaja HM, Griffin T, Devidas M, Asselin BL, Larson RS; Children's Oncology Group..

Blood. 2007 Sep 1;110(5):1429-38. Epub 2007 May 10. Erratum in: Blood. 2008 May 1;111(9):4830.


Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.

Uckun FM, Yang Z, Sather H, Steinherz P, Nachman J, Bostrom B, Crotty L, Sarquis M, Ek O, Zeren T, Tubergen D, Reaman G, Gaynon P.

Blood. 1997 May 15;89(10):3769-77.


Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

Raetz EA, Perkins SL, Bhojwani D, Smock K, Philip M, Carroll WL, Min DJ.

Pediatr Blood Cancer. 2006 Aug;47(2):130-40.


Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study.

Cleaver AL, Beesley AH, Firth MJ, Sturges NC, O'Leary RA, Hunger SP, Baker DL, Kees UR.

Mol Cancer. 2010 May 12;9:105. doi: 10.1186/1476-4598-9-105.


Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia.

Gottardo NG, Hoffmann K, Beesley AH, Freitas JR, Firth MJ, Perera KU, de Klerk NH, Baker DL, Kees UR.

Br J Haematol. 2007 May;137(4):319-28.


Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected].

Bhojwani D, Kang H, Menezes RX, Yang W, Sather H, Moskowitz NP, Min DJ, Potter JW, Harvey R, Hunger SP, Seibel N, Raetz EA, Pieters R, Horstmann MA, Relling MV, den Boer ML, Willman CL, Carroll WL; Children's Oncology Group Study.; Dutch Childhood Oncology Group.; German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia..

J Clin Oncol. 2008 Sep 20;26(27):4376-84. doi: 10.1200/JCO.2007.14.4519. Erratum in: J Clin Oncol. 2008 Nov 1;26(31):5142..


Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarrays.

Willenbrock H, Juncker AS, Schmiegelow K, Knudsen S, Ryder LP.

Leukemia. 2004 Jul;18(7):1270-7.


The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes.

Talby L, Chambost H, Roubaud MC, N'Guyen C, Milili M, Loriod B, Fossat C, Picard C, Gabert J, Chiappetta P, Michel G, Schiff C.

Leuk Res. 2006 Jun;30(6):665-76. Epub 2005 Nov 17.


Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival.

Chiaretti S, Li X, Gentleman R, Vitale A, Vignetti M, Mandelli F, Ritz J, Foa R.

Blood. 2004 Apr 1;103(7):2771-8. Epub 2003 Dec 18.


Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.

Manabe A, Ohara A, Hasegawa D, Koh K, Saito T, Kiyokawa N, Kikuchi A, Takahashi H, Ikuta K, Hayashi Y, Hanada R, Tsuchida M; Tokyo Children's Cancer Study Group..

Haematologica. 2008 Aug;93(8):1155-60. doi: 10.3324/haematol.12365. Epub 2008 Jun 2.


Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis.

Chiaretti S, Tavolaro S, Ghia EM, Ariola C, Matteucci C, Elia L, Maggio R, Messina M, Ricciardi MR, Vitale A, Ritz J, Mecucci C, Guarini A, Foà R.

Haematologica. 2007 May;92(5):619-26.


Are "early" and "late" T-acute lymphoblastic leukemias different diseases? A single center study of 34 patients.

Cascavilla N, Musto P, D'Arena G, Ladogana S, Melillo L, Carella AM, Perla G, Matera R, Carotenuto M.

Leuk Lymphoma. 1996 May;21(5-6):437-42.


Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.

Andersson A, Edén P, Lindgren D, Nilsson J, Lassen C, Heldrup J, Fontes M, Borg A, Mitelman F, Johansson B, Höglund M, Fioretos T.

Leukemia. 2005 Jun;19(6):1042-50.


Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia.

Chen JS, Coustan-Smith E, Suzuki T, Neale GA, Mihara K, Pui CH, Campana D.

Blood. 2001 Apr 1;97(7):2115-20.


The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.

Beesley AH, Cummings AJ, Freitas JR, Hoffmann K, Firth MJ, Ford J, de Klerk NH, Kees UR.

Br J Haematol. 2005 Nov;131(4):447-56.


Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia.

Thiel E, Kranz BR, Raghavachar A, Bartram CR, Löffler H, Messerer D, Ganser A, Ludwig WD, Büchner T, Hoelzer D.

Blood. 1989 Apr;73(5):1247-58.

Supplemental Content

Support Center